Meizhou City Hospital Of Guangdong Provience Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01540136
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Meizhou People's Hospital | Meizhou People's Hospital，Meizhou，China

Active Ingredients

Drugs in Phase 4 Trials (1)

budesonide (rhinocort) (1 trial)

Drugs in Phase 3 Trials (2)

cisplatin (platinol) (1 trial)

nedaplatin (1 trial)

Drugs in Phase 2 Trials (2)

almonertinib (1 trial)

oxaliplatin (eloxatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Colorectal Neoplasms (Phase 3)

Nasopharyngeal Carcinoma (Phase 3)

Peritoneal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5